Knowledge of Primary Health Care Physicians About the Novel Class of Type 2 Diabetes Medication in Qassim Province, Saudi Arabia

The study highlights significant gaps in CME among Qassim PHCC physicians, with only 36.1% trained in novel diabetes medications despite daily encounters with patients with T2DM. While awareness of GLP-1 RAs and other medications was high, variations in ADA guideline familiarity indicate a need for role-specific educational interventions. Physicians acknowledged GLP-1 RAs' superior HbA1c reduction and cardiovascular benefits. Policymakers should prioritize targeted CME programs, enhance access to updated guidelines, and promote tailored training to bridge knowledge and practice gaps.